About the Pharmaceutical Contract Manufacturing Services Market
A CMO, also known as contract development and manufacturing organization, is a firm that serves pharmaceutical innovator companies on a contract basis for services across the pharmaceutical supply chain, ranging from formulation development to drug manufacturing. Large pharmaceutical innovator companies enlist these services to focus on core activities such as R&D for novel drugs, drug discovery, and drug marketing. The category spend momentum is attributed to the cost savings of about 28%-32% that contract manufacturing of drugs enables while enhancing the drug development process. CMOs provide access to novel technologies and innovative platforms that can enhance speed-to-market and help buyers to remain competitive.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmaceutical Contract Manufacturing Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Pharmaceutical Contract Manufacturing Services Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category drivers
- Advances in medical science such as stem cell research and combination drug therapy
- For a full, detailed list, view the report
Category management strategy
- Rationalization of the supply base
- For a full, detailed list, view the report
Procurement best practices
- Establish quality enhancement programs for suppliers
- For a full, detailed list, view the report
Key questions answered in this report
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints on category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
- What are the procurement best practices in this market?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive Summary
Global category spend
Category spend growth
Spend segmentation by region
Regional spend dynamics
Regional influence on global spend
Regional spend opportunity for suppliers
PART 02: Market Summary
PART 03: Category Pricing Insights
Pricing outlook
Supplier cost structure
Outlook for input costs
Total cost of ownership analysis
Overview of pricing models
Comparison of pricing models
Supply chain margins
Cost drivers impacting pricing
Volume drivers impacting pricing
PART 04: Cost-Saving Opportunities
Supplier-side levers
Buyer-side levers
Quantifying cost-saving opportunities
Quantifying cost savings by negotiation strategies
PART 05: Best Practices
Innovation and success stories
Procurement excellence best practices
Procurement best practices
Sustainability practices
PART 06: Category Ecosystem
Market favorability index for suppliers
Competitiveness index for suppliers
Buyer power
Supplier power score
Threat of new entrants
Threat of substitutes
Buyer ecosystem
Supplier ecosystem
PART 07: Category Management Strategy
Category management objectives
Supplier and buyer KPIs
Outsourcing category management activities
Risk management
PART 08: Category Management Enablers
Procurement organization
Category enablers
PART 09: Suppliers Selection
RFx essentials
Supplier selection criteria
Service level agreement
Incumbent supplier evaluation metrics
PART 10: Suppliers Under Coverage
Overview
Supplier positioning
Profile: Pfizer
Profile: Boehringer Ingelheim
Profile: Lonza
Profile: Baxter
Profile: Catalent
Profile: Fresenius Kabi
PART 11: US Market Insights
Category spend in the US
Price outlook
Supplier cost structure in the US
Margins of suppliers in the US
Category cost drivers
Category volume drivers
Overview of best practices in the US
Procurement best practices in the US
US supply market overview
Supplier positioning for the US
Regional category risks
PART 12: Category Definition
Category hierarchy
Category scope
Category map
PART 13: Appendix
List of abbreviations
Key Notes
List of Exhibits
Global category spend (2018-2023)
Category spend growth (2018-2023)
Regional spend dynamics
Regional spend dynamics
Comparison of category maturity across regions
Regional spend opportunity for suppliers (2018-2023)
Category pricing dynamics
Supplier cost breakup
Input cost dynamics
Total cost of ownership model
Benefit comparison of pricing models
Pricing models – comparison matrix
Supplier margin analysis
Margin analysis across supply chain
Cost drivers
Volume drivers
Cost-saving opportunities: Supply-side levers
Cost-saving opportunities: Demand-side levers
Cost-saving opportunity matrix
Negotiation grid
Innovation and success stories
Procurement excellence summary: Impact on the category
Supplier relationship management metrics
Strategic sourcing and category management metrics
Technology-facilitated procurement metrics
Procurement best practices dashboard
Sustainability practices: Impact on the category
Sustainability best practices
Market environment score
Market competitiveness score
Buyer power score
Supplier power score
Ease of market entry score
Ease of substitution score
Buyer ecosystem: Outlook
Supplier ecosystem: Outlook
Ecosystem disruption threats
Key category management objectives
Supplier KPI dashboard: Importance for the category
Buyer KPI dashboard: Importance for the category
Category management enablers
Risk management matrix
Category enablers: Organization
Category enablers: Technology
RFx questions
Phase I RFI considerations
SLA terms
Supplier performance benchmarking criteria
Supplier operational capability matrix
Supplier positioning matrix
Pfizer – Key information dashboard
Boehringer Ingelheim – Key information dashboard
Lonza – Key information dashboard
Baxter – Key information dashboard
Catalent – Key information dashboard
Fresenius Kabi – Key information dashboard
US category spend (2018-2023)
Category pricing dynamics
Supplier cost breakup
Supplier margin analysis
Margin analysis across supply chain
Cost drivers
Volume drivers
Procurement excellence summary: Impact on the category
Supplier relationship management
Strategic sourcing and category management
Technology-facilitated procurement
Procurement best practices dashboard
Supplier operational capability matrix
Supplier positioning matrix
Risk management matrix
Category definition
Category nuances
Importance of category relative to other categories
Executive Summary
New Report Released: Global Pharmaceutical Contract Manufacturing Service Category - Procurement Market Intelligence Report 2018-2022.The author of the report recognizes the following companies as the key suppliers in the Global Pharmaceutical Contract Manufacturing Service Category - Procurement Market Intelligence Report: Pfizer CentreOne, Boehringer Ingelheim, Lonza, Baxter, and Patheon.
Commenting on the report, an analyst from the research team said: “One of the procurement best practices for buyers in the global pharmaceutical contract manufacturing service market is to establish a supplier quality enhancement program.”
According to the report, one of the key growth drivers for the global pharmaceutical contract manufacturing service market is the high demand for pharmaceutical contract manufacturing services from biopharmaceutical industry. The biopharmaceutical industry is increasingly outsourcing services to CMOs due to the need for additional capacity and access to capabilities and technologies that they lack.
Further, the report states that one of the key procurement challenges faced by buyers is the difficulty in demand forecasting for biologic drug production. The biologics drug development and approval process are long and fraught with complications, resulting in risk of inaccurately forecasting demand.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Companies Mentioned
- Pfizer
- Boehringer Ingelheim
- Lonza
- Baxter
- Catalent
- Fresenius Kabi
Methodology
LOADING...
